EUVIMEDEUVIMED entdecken
Systematische ÜbersichtLeitlinieOpen Access · CC BY 4.0

Consensus guidelines for sarcopenia prevention, diagnosis and management in Australia and New Zealand

Jesse Zanker iD, Marc Sim, Kate Anderson, Saliu Balogun, Sharon L Brennan-Olsen, Elsa Dent, Gustavo Duque, Christian M Girgis, Mathis Grossmann, Alan Hayes, Tim Henwood, Vasant Hirani und 17 weitere

Journal of Cachexia, Sarcopenia and Muscle · 2023-02 · 14 (1) · 142-156

DOI: 10.1002/jcsm.13115 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift Journal of Cachexia, Sarcopenia and Muscle, online erschienen am 09.11.2022. Verfasst von Jesse Zanker und 28 weiteren Autor:innen. Beteiligte Einrichtung: Australian Institute for Musculoskeletal Science (AIMSS), The University of Melbourne and Western Health, St. Albans, Victoria, Australia. Hauptthemen laut MEDLINE: Resistance Training, Sarcopenia. Die Arbeit wurde bisher 153-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Australian National Health and Medical Research Council Investigator, Australian Medical Research Future Fund, NHMRC.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Sarcopenia is an age‐associated skeletal muscle condition characterized by low muscle mass, strength, and physical performance. There is no international consensus on a sarcopenia definition and no contemporaneous clinical and research guidelines specific to Australia and New Zealand. The Australian and New Zealand Society for Sarcopenia and Frailty Research (ANZSSFR) Sarcopenia Diagnosis and Management Task Force aimed to develop consensus guidelines for sarcopenia prevention, assessment, management and research, informed by evidence, consumer opinion, and expert consensus, for use by health professionals and researchers in Australia and New Zealand.

Methods

A four‐phase modified Delphi process involving topic experts and informed by consumers, was undertaken between July 2020 and August 2021. Phase 1 involved a structured meeting of 29 Task Force members and a systematic literature search from which the Phase 2 online survey was developed (Qualtrics). Topic experts responded to 18 statements, using 11‐point Likert scales with agreement threshold set a priori at >80%, and five multiple‐choice questions. Statements with moderate agreement (70%–80%) were revised and re‐introduced in Phase 3, and statements with low agreement (80%) were confirmed by the Task Force in Phase 4.

Conclusions

The ANZSSFR Task Force present 17 sarcopenia management and research recommendations for use by health professionals and researchers which includes the recommendation to adopt the EWGSOP2 sarcopenia definition in Australia and New Zealand. This rigorous Delphi process that combined evidence, consumer expert opinion and topic expert consensus can inform similar initiatives in countries/regions lacking consensus on sarcopenia.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Resistance TrainingSarcopeniaAdultAgedFemaleHumansMaleMiddle AgedAustraliaConsensusNew Zealand

Stichwörter der Autor:innen

AgedGeriatric assessmentMass screeningSarcopenia

Autor:innen und Institutionen

  • Australian Institute for Musculoskeletal Science (AIMSS), The University of Melbourne and Western Health, St. Albans, Victoria, Australia.
  • Department of Medicine - Western Health, The University of Melbourne, St. Albans, Victoria, Australia.
  • Nutrition & Health Innovation Research Institute, School of Medical and Health Sciences, Edith Cowan University, Joondalup, Western Australia, Australia.
  • School of Medicine, University of Western Australia, Perth, Western Australia, Australia.
  • Institute for Health Transformation - Determinants of Health, Faculty of Health, Deakin University, Burwood, Victoria, Australia.
  • School of Health and Social Development, Faculty of Health, Deakin University, Burwood, Victoria, Australia.

ORCID-Profile: Jesse Zanker

Förderung

  • Australian National Health and Medical Research Council Investigator
  • Australian Medical Research Future Fund
  • NHMRC
  • MRFF
  • Deakin University
  • Amgen
  • Department of Health and Human Services (DHHS)
  • Norman Beischer Foundation

Zitieren

APA

Zanker, J., Sim, M., Anderson, K., Balogun, S., Brennan-Olsen, S. L., Dent, E., Duque, G., Girgis, C. M., Grossmann, M., Hayes, A., Henwood, T., Hirani, V., Inderjeeth, C., Iuliano, S., Keogh, J., Lewis, J. R., Lynch, G. S., Pasco, J. A., Phu, S., …, & Scott, D. (2023). Consensus guidelines for sarcopenia prevention, diagnosis and management in Australia and New Zealand. Journal of Cachexia, Sarcopenia and Muscle, 14(1), 142-156. https://doi.org/10.1002/jcsm.13115

Vancouver

Zanker J, Sim M, Anderson K, Balogun S, Brennan-Olsen SL, Dent E, et al. Consensus guidelines for sarcopenia prevention, diagnosis and management in Australia and New Zealand. Journal of Cachexia, Sarcopenia and Muscle. 2023;14(1):142-156. doi:10.1002/jcsm.13115

BibTeX
@article{Zanker2023,
  author = {Zanker, Jesse and Sim, Marc and Anderson, Kate and Balogun, Saliu and Brennan-Olsen, Sharon L and Dent, Elsa and Duque, Gustavo and Girgis, Christian M and Grossmann, Mathis and Hayes, Alan and Henwood, Tim and Hirani, Vasant and Inderjeeth, Charles and Iuliano, Sandra and Keogh, Justin and Lewis, Joshua R and Lynch, Gordon S and Pasco, Julie A and Phu, Steven and Reijnierse, Esmee M and Russell, Nicholas and Vlietstra, Lara and Visvanathan, Renuka and Walker, Troy and Waters, Debra L and Yu, Solomon and Maier, Andrea B and Daly, Robin M and Scott, David},
  title = {Consensus guidelines for sarcopenia prevention, diagnosis and management in Australia and New Zealand},
  journal = {Journal of Cachexia, Sarcopenia and Muscle},
  year = {2023},
  volume = {14},
  number = {1},
  pages = {142--156},
  doi = {10.1002/jcsm.13115}
}
Kostenlos starten →